HHG Capital - Tradeable Rights - Feb 2026 EBIT

The latest EBIT for HHGCR is $-320K as of March 2024. That compares with $-570K in the prior-year period — up 43.8% year over year. That is above the sector sector average of $-77M. Investors often review this figure alongside HHG Capital - Tradeable Rights - Feb 2026's historical trend and sector peers before judging valuation or financial health.

Over the past year, HHGCR's EBIT moved from $-570K to $-320K — a 43.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HHG Capital - Tradeable Rights - Feb 2026's operating scale or balance-sheet position.

Against its sector companies, HHGCR currently prints $-320K for EBIT, while the sector average sits near $-77M. That is roughly 99.6% above the sector mean. Large gaps often invite a closer look at HHG Capital - Tradeable Rights - Feb 2026's growth, margins, and balance sheet.

A EBIT figure of $-320K for HHGCR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting HHGCR's EBIT ($-320K), review year-over-year change from $-570K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.